Phase 4 N=50 Lymphedema Study for Arm or Leg Lymphedema
Lymphedema
Primary: Part 1: Count of Participants Able to Complete Ketoprofen Treatment — 50 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=12 Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
Healthy Subject
Primary: Change in Hand Volume Following Tourniquet Use — 15.0; 12.1; 12.5; 7.9 mL
Phase 2 N=82 Acupuncture for Chronic Lymphedema
Breast Cancer With Chronic Lymphedema
Primary: Lymphedema as Measured at Baseline and at 6 Weeks — 4.74; 4.82; 4.29; 4.76 cm
N/A N=18 Imaging Biomarkers of Lymphatic Dysfunction
Secondary Lymphedema
Primary: Assessing a Change in Bioimpedance Spectroscopy (BIS) — 1.3; 1.8 Change of score on a scale
Phase 2 N=10 A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer
Lymphedema
Primary: Change in Volume Ipsilateral Lymphedema in Arm — -161.0; -372.8 mL — p=0.0658
N/A N=23 Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture.
Edema Arm · Fracture; Wrist
Primary: Thumb Circumference — -0.2; 0 cm
N/A N=1 Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
Lymphedema · Edema
Primary: Change in Limb Volume — -15; -202 mL
N/A N=13 Upper Extremity Lymphatic Mapping for Breast Cancer Patients
Breast Cancer · Axillary Lymph Node Dissection
Primary: Number and Prevalence of Metastases of Blue Nodes in the ALND Specimen (Nodes Draining the Breast). — 0 participants
N/A N=75 Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Lymphedema · Breast Cancer
Primary: Number of Participants With Successful Assessment of Lymphedema by Multiple Frequency Bioimpedance Spectroscopy — 19; 21; 22 participants
N/A N=37 Evaluation of the Ulthera® System for Treatment of the Brachia
Brachial Ptosis
Primary: Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity — 48 percentage of participants improved
N/A N=191 Evaluation of BIS for Quantification of Lymphedema
Breast Cancer
Primary: Correlation of Impedance Ratios Obtained Through Bioimpedance Spectroscopy (BIS) With Perometric Relative Arm Volume Change (RVC) — 0.195 correlation coefficient…
N/A N=30 CoolSculpting the Upper Arm Study
Body Fat Disorder
Primary: Percentage of Pre-treatment Images Correctly Identified — 85.2 percent correctly identified images
N/A N=15 CoolSculpting Treatment in the Upper Arms
Body Fat Disorder
Primary: Proportion of Correctly Identified Pre-treatment Photos — 26 photos
N/A N=36 Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling)
Lipedema · Lipolymphedema
Primary: Change in Circumferential Measurements Over Time — -0.5; -1.0; -1.3; -2.0 cm
N/A N=24 Study to Evaluate the Safety and Effectiveness of Dayspring for Lower Extremity Lymphedema
Lymphedema · Lymphedema Lower Extremity · Chronic Venous Insufficiency
Primary: LYMQOL (LYMphedema Quality of Life) ***All Relevant Time Points Used in the Calculation in the Time Frame (e.g., Baseline and 3 Months).*** — .83 units on a scale
N/A N=28 Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device
Lymphedema, Secondary · Lymphedema of Upper Limb
Primary: Recruitment Rates — 32.5; 37.5 rate of recruitment
Phase 1 N=47 A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)
Hypertension
Primary: Change From Baseline in Segmental Bioimpedance Measurements at 10 Kilohertz (KHz) at Week 2 — -7.9; 3.8 Ohms — p=0.001
Phase 4 N=50 Low Level Laser Treatment and Breast Cancer Related Lymphedema
Lymphedema
Primary: LDex Change- — 28.0; 17.8; 22.2 LDex
N/A N=9 Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)
Breast Cancer · Upper Extremity Lymphedema
Primary: Volume Changes as Measured by Perometry
N/A N=82 Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage
Lymphedema
Primary: Percent Volume Change of Affected Limb at End of Treatment Compared to Baseline. — -14.56; -7.09; -10.24; -9.84 % volume change measured in mL.
N/A N=21 Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device
Lower Extremity Lymphoedema · Leg Lymphoedema
Primary: Limb Volume (ml) — -197; -60; 45 ml
N/A N=34 Vasculera in Participants With Lipedema
Lipedema
Primary: Change in Weight From Baseline — 0.340 kilograms — p=0.473
N/A N=80 Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes
Edema
Primary: Cutaneous Water Content — -1.1; -.82; -0.99; -2.1 percentage change in dielectric constant — p=>0.05
N/A N=62 Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference
Body Contouring
Primary: Change in Combined Upper Arm Circumference Measurements From Baseline to Endpoint — 18; 1 participants
N/A N=47 Compression Stocking Use in Shoulder Arthroscopy in Beach Chair
Obesity · Shoulder Impingement
Primary: Cerebral Desaturation Event — 17; 22; 7; 1 Participants — p=.0553
Phase 2 N=54 Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)
Lymphedema
Primary: Change in Skin Thickness of the Calf of the Most Affected Leg, Measured by Skinfold Calipers — -6.83; -7.75 mm
N/A N=568 Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
Lymphedema
Primary: Number of Participants Who Were Lymphedema-free 18 Months After Randomization — 114; 135 Participants
N/A N=6 Effects of a Compliant Arm Support on Post-stroke Upper Extremity Range of Motion
Arm Weakness as a Consequence of Stroke
Primary: Percent Change From Baseline in Reachable Workspace — 27; -71 percent change
N/A N=47 Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer
Arm Lymphedema · Truncal Lymphedema · Breast Cancer
Primary: Arm Volume at End of Study — 2376.52; 2539.93 ml
N/A N=43 Patient Anxiety Associated With Lymphedema Surveillance Method
Anxiety
Primary: Anxiety — 7.1; 8.8 units on a scale